# Weiss Ratings Type: Company Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/weiss-ratings Canonical HTML page: https://getfinancebrief.com/entity/weiss-ratings ## Timeline - **2026-07-22**: Quarterly earnings released — SMBC reports EPS of $1.83 vs. $1.52 estimate, revenue of $51.77M. - **2026-07-15**: Q2 2026 Earnings Release — Home BancShares reports Q2 EPS of $0.64, beating consensus of $0.62; stock rises 1%. - **2026-07-08**: Wells Fargo Cuts Target to $70 — Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside. - **2026-07-01**: Bank of America Lowers Target — Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating. - **2026-06-26**: Piper Sandler adjusts PT — Piper Sandler reiterates Neutral, boosts target from $71 to $79. - **2026-06-15**: Piper Sandler Stays Overweight — Piper Sandler reaffirms an Overweight rating on Freshpet shares. - **2026-06-11**: Three directors execute insider purchases — Philip Fracassa buys 5,000 MBC shares, Paul Koonce buys 500 SR shares, and Frederick Disanto buys 1,000 EML shares, all in open-market transactions. - **2026-06-05**: Insider sale by EVP Windes — EVP Richard Windes sells 2,000 shares at average $69.70, totaling $139,400. - **2026-06-04**: Weiss Ratings reiterates Buy — Weiss Ratings issues a 'buy (b)' rating on SMBC. - **2026-06-03**: Dividend Payment — Quarterly dividend of $0.21 per share paid to shareholders of record on May 13. - **2026-06-01**: Weiss Ratings Downgrades — Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'. - **2026-05-26**: Weiss Ratings Downgrades — Weiss Ratings downgrades Home BancShares from Buy (B-) to Hold (C+). - **2026-05-19**: Cantor Fitzgerald Reiterates Neutral — Cantor Fitzgerald reiterates a Neutral rating and lowers price target to $30 from $31. - **2026-05-13**: Dividend Record Date — Stockholders of record as of this date eligible for $0.21 quarterly dividend; also ex-dividend date. - **2026-05-12**: Eastern reports Q1 2026 earnings — EML delivers $0.11 EPS, missing the $0.50 estimate by $0.39; revenue of $59.68M trails the $67.74M consensus. ## Recent coverage (10 stories) ### Wabtec FY26 EPS $10.60-$10.90, Moody's $16.50-$17.00: Both Miss Consensus 2026-07-23 02:24:25 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Wabtec guided revenue between $12.3-$12.6B and EPS slightly below the Street, while Moody’s EPS range also came in under estimates. Analysts remain constructive with moderate buy ratings and double-digit upside targets for both stocks. Full story: https://getfinancebrief.com/story/wabtec-moodys-fy26-guidance-analysis ### SMBC Beats EPS by $0.31, Stock Down 1.4% Amid Insider Selling 2026-07-23 00:54:41 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Southern Missouri Bancorp delivered a strong quarter with earnings of $1.83 per share, beating estimates by $0.31 on revenue of $51.77 million. However, the stock fell 1.4% to $75.41 as analysts remain divided and insider selling raises questions. Full story: https://getfinancebrief.com/story/smbc-earnings-beat-stock-down-insider-sell ### MCRI Beats Q2 EPS by $0.11; $2.21B Casino Stock Eyes $144 Target Amid Insider Sale 2026-07-21 01:35:47 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Monarch Casino & Resort posted a second-quarter earnings beat of $0.11 per share on revenue strength, driving the stock up 1.1% to $124.38. Valuation metrics remain solid with a P/E of 21.08 and a 1% dividend yield, but a recent CEO stock sale and mixed analyst ratings signal a cautious bias. Truist’s $144 price target offers the most bullish outlook, while Stifel sits at $102. Full story: https://getfinancebrief.com/story/mcri-earnings-beat-011-eps-analyst-targets-insider-sale ### WaFd Misses EPS by $0.02, Stock Near $39.49 High: Buy the Dip or Take Profits? 2026-07-17 04:04:47 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 WaFd (WAFD) reported quarterly EPS of $0.81, missing consensus by 2.4%, while the stock trades near a 52-week high and offers a 2.7% dividend yield. Analysts are split between hold and buy, and an insider sale adds caution. For income-focused investors, the small miss may be overshadowed by the stable payout and institutional accumulation. Full story: https://getfinancebrief.com/story/wafd-earnings-miss-eps-dividend-finance-analysis ### HOMB Q2 EPS Trumps Estimates by $0.02, Stock Yields 2.9% 2026-07-16 00:35:23 · Sentiment: Bullish · Impact: 6/10 · Sources: 2 Home BancShares delivered a $0.64 per share Q2 profit, edging past consensus by $0.02. The bank's 32.48% net margin and conservative balance sheet keep it as a defensive play in a shaky regional banking sector. With a P/E of 12 and a 2.9% dividend yield, HOMB offers income and value in a stock that barely moved on the beat. Full story: https://getfinancebrief.com/story/home-bancshares-q2-2026-earnings-beat ### Aehr Test Systems Beats Q4 EPS by $0.06, Stock Jumps 5.9% — What’s Next? 2026-07-15 08:35:12 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Aehr Test Systems reported Q4 earnings of $0.05 per share, beating the consensus estimate of -$0.01 by $0.06. Despite negative net margins of -25.23% and insider selling, shares surged 5.9% to $72.01, with analysts mixed — two buys, one hold, one sell, and a Hold consensus with a $68 target. Full story: https://getfinancebrief.com/story/aehr-earnings-beat-006-stock-surges ### ResMed Targets Drop to $225 at Wells Fargo; Upside Remains at +23.2% 2026-07-10 14:15:12 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Wells Fargo’s $225 target is the lowest among major banks, yet ResMed’s average analyst target of $270.64 implies a 23.2% upside. Markets weigh defensive balance sheet qualities against emerging therapeutic competition. Full story: https://getfinancebrief.com/story/resmed-stock-analyst-target-cuts-wells-fargo ### Wells Fargo Cuts Freshpet Target to $70, Still Sees 28% Upside 2026-07-09 13:12:08 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Wells Fargo lowered its price target on Freshpet to $70 from $75 while maintaining an Overweight rating, implying the stock is undervalued by 28%. The market remains skeptical with FRPT trading at $54.51, well below the consensus analyst target of $74.25. Analysts overall rate the pet food company a Moderate Buy, despite a string of recent target cuts. Full story: https://getfinancebrief.com/story/wells-fargo-cuts-freshpet-target-70-upside ### Insiders Pour $106K Into EML, SR, MBC as Directors Boost Stakes by Up to 12.49% 2026-06-14 11:22:29 · Sentiment: Neutral · Impact: 5/10 · Sources: 3 Three corporate directors executed open-market purchases totaling $106,030 on June 11, signaling potential undervaluation at Eastern, Spire, and MasterBrand. The buys ranged from a 0.99% stake boost at Eastern to a 12.49% jump at MasterBrand, despite mixed earnings and sell-side downgrades. Full story: https://getfinancebrief.com/story/insider-buying-spree-2026-eastern-spire-masterbrand ### POSCO and Ituran Scale New 52-Week Highs Amid Divergent Analyst Sentiment 2026-02-21 12:09:42 · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Industrial giant POSCO and telematics leader Ituran Location and Control both reached one-year price peaks on Friday, signaling resilient momentum in the steel and automotive technology sectors. Despite the technical strength, a 'sell' rating from Weiss Ratings for POSCO highlights a growing gap between market price action and fundamental valuation models. Full story: https://getfinancebrief.com/story/posco-ituran-52-week-highs-analysis --- This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.